Chembio shares double on order of $28 million COVID diagnostic test

Shares of Chembio Diagnostics (CEMI) – Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 antigen testing in Brazil.

.